Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2

Published:2008 Issue:2 Volume:104 Page:680-691
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Nagai Tadashi,Kikuchi Satoru,Ohmine Ken,Miyoshi Takuji,Nakamura Makiko,Kondo Takahito,Furuyama Kazumichi,Komatsu Norio,Ozawa Keiya

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference34 articles.

1. Deregulated degradation of the cdk inhibitor p27 and malignant transformation

2. Hemin Confers Resistance to Imatinib (Glivec)-Induced Cell Death but Enhances Nilotinib (AMN107) Cytotoxicity in Human K-562 CML Leukemia Cells.

3. Apoptosis and leukaemia

4. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

5. The development of imatinib as a therapeutic agent for chronic myeloid leukemia

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions;Current Research in Pharmacology and Drug Discovery;2021

2. Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments;BioMed Research International;2019-11-18

3. Teraphtal decreased the sensitivity tumor cells to doxorubicine in vitro but does not affect its antitumor effect in vivo .;Russian Journal of Biotherapy;2019-06-15

4. Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies;Cancer Drug Resistance;2019

5. Where is the Clinical Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics?;Current Pharmaceutical Design;2018-10-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3